TILs Plus Third-Generation EGFR-TKI Therapy for TKI-Resistant NSCLC

Clinical trial NCT07498595 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07498595
Sponsor: Tianjin Medical University General Hospital
Status: NOT_YET_RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

EGFR-TKI-resistant Non-Small Cell Lung Cancer

Start date: 2026-03-31
Primary completion: 2028-03-31
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.